| 2026-03-27 |
详情>>
股本变动：
变动后总股本814.78万股
|
| 2026-03-27 |
详情>>
业绩披露：
2025年年报每股收益-8.62美元,归母净利润-1395.8万美元,同比去年增长19.41%
|
| 2026-03-18 |
复牌提示：
2026-03-18 10:03:44 停牌，复牌日期 2026-03-18 10:08:44
|
| 2026-03-16 |
详情>>
内部人交易：
CHEMEROW DAVID I.等共交易2笔
|
| 2025-11-17 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-8.18美元,归母净利润-978.3万美元,同比去年增长13.83%
|
| 2025-10-29 |
股东大会：
将于2025-12-16召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Company’s Board of Directors (the “Board”), each to serve until the Company’s 2026 Annual Meeting of Stockholders, until his or her respective successor is duly elected and qualified or until his or her earlier death, resignation or removal;
2.To ratify, on a non-binding advisory basis, the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To approve, on a non-binding advisory basis, the frequency of an advisory vote on executive compensation.
5.Transact such other business as may properly come before the Annual Meeting.
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-8.88美元,归母净利润-649.9万美元,同比去年增长15.08%
|
| 2025-05-15 |
详情>>
业绩披露：
2025年一季报每股收益-0.05美元,归母净利润-370.5万美元,同比去年增长36.31%
|
| 2025-04-02 |
股东大会：
将于2025-04-30召开股东大会
会议内容 ▼▲
- 1.To approve a series of alternate amendments to our Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock at a ratio in the range of up to 1-for-100, with such ratio to be determined by our Board of Directors in its sole discretion. We refer to this proposal as the “Reverse Stock Split Proposal” or “Proposal 1.”
|
| 2025-03-27 |
详情>>
业绩披露：
2024年年报每股收益-0.31美元,归母净利润-1732万美元,同比去年增长40.20%
|
| 2024-11-15 |
财报披露：
美东时间 2024-11-15 盘前发布财报
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.21美元,归母净利润-1135.3万美元,同比去年增长30.72%
|
| 2024-11-06 |
股东大会：
将于2024-12-17召开股东大会
会议内容 ▼▲
- 1.To elect each of Mr. Kellner, Mr. Deutsch, Mr. Chioini and Mr. Sweeney to hold office until the 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”), until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal;
2.To ratify the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To vote against the proposal to approve, by non-binding vote, executive compensation;
4.To transact such other business as may properly come before the Annual Meeting.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益-0.15美元,归母净利润-765.3万美元,同比去年增长10.70%
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.12美元,归母净利润-581.7万美元,同比去年增长-58.89%
|
| 2024-04-01 |
详情>>
业绩披露：
2023年年报每股收益-0.6美元,归母净利润-2896.2万美元,同比去年增长-48.94%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.34美元,归母净利润-1638.6万美元,同比去年增长-8.83%
|
| 2023-11-01 |
股东大会：
将于2023-12-01召开股东大会
会议内容 ▼▲
- 1.To elect each of Mr. Kellner, Mr. Deutsch and Mr. Chioini to hold office until the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”), until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal;
2.To ratify the selection of BDO USA, P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To vote against the proposal to approve, by non-binding vote, executive compensation;
4.To recommend, by non-binding vote, the frequency of executive compensation votes;
5.To transact such other business as may properly come before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-17 |
股东大会：
将于2021-10-07召开股东大会
会议内容 ▼▲
- 1.To elect three members to the Board of Directors of the Company to serve until their respective successors are elected and qualified;
2.To ratify the selection by the Company’s Audit Committee of BDO USA, LLP independent registered public accounting firm, to audit the financial statements of the Company for the year ending December 31, 2021;
3.To approve, by non-binding vote, executive compensation;
4.To transact such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2020-08-11 |
股东大会：
将于2020-10-07召开股东大会
会议内容 ▼▲
- 1.To elect three members to the Board of Directors of the Company to serve until their respective successors are elected and qualified;
2.To ratify the selection by the Company’s Audit Committee of Morrison, Brown, Argiz & Farra, LLC independent registered public accountants, to audit the financial statements of Company for the year ending December 31, 2020;
3.To approve, by non-binding vote, executive compensation;
4.To transact such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2019-08-20 |
股东大会：
将于2019-10-03召开股东大会
会议内容 ▼▲
- 1.To elect three members to the Board of Directors of Hemispherx to serve until their respective successors are elected and qualified;
2.To ratify the selection by Hemispherx’s Audit Committee of Morrison, Brown, Argiz & Farra, LLC independent registered public accountants, to audit the financial statements of Hemispherx for the year ending December 31, 2019;
3.To approve, by non-binding vote, executive compensation;
4.To Approve an amendment to the Company’s 2018 Equity Incentive Plan to increase the number of shares of Common Stock available under such plan.
5.To transact such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2019-06-11 |
详情>>
拆分方案：
每44.0000合并分成1.0000股
|
| 2019-04-24 |
股东大会：
将于2019-05-29召开股东大会
会议内容 ▼▲
- 1.To approve the grant of discretionary authority to our Board of Directors to amend our Certificate of Incorporation to effect a reverse stock split of our issued and outstanding Common Stock at a ratio within the range of 1-for-20 to 1-for-50, as selected by our Board of Directors;
2.To transact such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2018-08-03 |
股东大会：
将于2018-09-12召开股东大会
会议内容 ▼▲
- 1.To elect three members to the Board of Directors of Hemispherx to serve until their respective successors are elected and qualified;
2.To ratify the selection by Hemispherx’s Audit Committee of Morrison, Brown, Argiz & Farra, LLC independent registered public accountants, to audit the financial statements of Hemispherx for the year ending December 31, 2018;
3.To approve, by non-binding vote, executive compensation;
4.To approve the Hemispherx 2018 Equity Incentive Plan;
5.To approve, by non-binding vote, a name change from Hemispherx Biopharma, Inc. to Amplified Immune Modulation Inc.
6.To transact such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2017-07-18 |
股东大会：
将于2017-09-13召开股东大会
会议内容 ▼▲
- 1. To elect three members to the Board of Directors of Hemispherx to serve until their respective successors are elected and qualified;
2. To ratify the selection by Hemispherx’s Audit Committee of RSM US LLP, independent registered public accountants, to audit the financial statements of Hemispherx for the year ending December 31, 2017;
3. To approve, by non-binding vote, executive compensation;
4. To recommend, by non-binding vote, the frequency of executive compensation votes;
5. To transact such other matters as may properly come before the meeting or any adjournment thereof.
|
| 2016-08-17 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2016-06-27 |
股东大会：
将于2016-08-17召开股东大会
会议内容 ▼▲
- 1. To elect four members to the Board of Directors of Hemispherx to serve until their respective successors are elected and qualified;
2. To ratify the selection by Hemispherx’s Audit Committee of RSM US LLP, independent registered public accountants, to audit the financial statements of Hemispherx for the year ending December 31, 2016;
3. To authorize Hemispherx’s Board of Directors to amend Hemispherx’s Certificate of Incorporation to effect, at its sole discretion, a reverse stock split of outstanding shares of Hemispherx’s Common Stock by a ratio in the range of 8-to-1 to 12-to-1 (the “Reverse Stock Split”), with the Board having the discretion as to whether or not the Reverse Stock Split is to be effected, and with the exact ratio to be set within the above range, as determined by the Board in its discretion;
4. To approve, by non-binding vote, executive compensation;
5. To transact such other matters as may properly come before the meeting or any adjournment thereof.
|